Sánchez-Torres LJ, Santos-Hernández M, Porthos-Salas A, Carmona-Rendón R, Alvarado-Reyes R

Language: Spanish
References: 14
Page: 269-273
PDF size: 368.45 Kb.

ABSTRACT

Immunosuppression therapy has resulted in a decrease in rejection complications in kidney transplantation patients, but unfortunately the appearance of de novo tumors in these patients has been observed. The purpose of this article was to present the clinical case of a kidney transplantation patient that developed a bone angiosarcoma after 4 years of immunosuppression therapy. The clinical case of a malignant bone tumor in the left iliopubic region that was surgically treated with a type II + III internal hemipelvectomy without reconstruction is described in detail. The patient presented with infectious and scarring complications.
Immunosuppression medications have improved the quality of life of transplantation patients by reducing rejection. However, the appearance of tumors in a high percentage of these patients has been observed.
Tumor presentation in immunosuppressed patients due to kidney transplantation is directly proportionate to the immunosuppression intensity and duration. The most common tumors to develop are skin cancers and lymphomas, not bone angiosarcoma. Internal hemipelvectomy is not routinely performed and it has a high complication rate.

REFERENCES

1. Campistol JM, Morales JM. Manejo de los tumores tras el trasplante renal. Nefrología 2009;29(Supp2):33-45.

2. Gómez-Roel X, León-Rodríguez E. Neoplasias malignas en receptores de trasplante renal. Rev Invest Clin 2005;57(2):225-229.

3. Dorfman HD, Czerniak B. Vascular lesions. In: Dorfman HD, Czerniak B (editors). Bone tumors. St. Louis, Mo. Mosby. 1998. 729-814.

4. Sánchez-Torres LJ, Santos-Hernández M, Carmona-Rendón R, et al. Neoplasias malignas en pelvis y su resección. Acta Ortop Mex 2009;23(4):237-242.

5. Shin KH, Rougraff BT, Simon MA. Oncologic outcomes of primary bone sarcomas of the pelvis. Clin Orthop Relat Res 1994;(304):207-217.

6. Donati D, El Ghoneimy A, Bertoni F, et al. Surgical treatment and outcome of conventional pelvic chondrosarcoma. J Bone Joint Surg Br 2005;87(11):1527-1530.

7. Makhson A. Extralesional resection for tumours of the pelvic bones. Int Orthop 1997;21(1):41-45.

8. Bhagat S, Sharma H, Pillai DS, et al. Pelvic Ewing’s sarcoma a review from Scottish bone tumour registry. J Orthop Surg (Hong Kong) 2008;16(3):333-338.

9. Hermida GJF, Moreno SJM, Fernández PC, et al. Cáncer como complicación de trasplante renal. Clínicas Urológicas de la Complutense 1999;6:463-488.

10. Virto J, Orbe J, Lampreabe I, et al. Análisis estadístico de la incidencia de cánceres de novo en pacientes trasplantados renales: una nueva metodología de estudio. Nefrología 2003;XXIII(5):395-398.

11. Uribe UNO, Robledo NJC, Gamboa DA. Caso de angiosarcoma de pelvis asociado a angiomatosis de columna. Rev Invest Clin 1996;48(1):49-53.

12. Sánchez-Torres LJ, Santos-Hernández M. Complicaciones en hempelvectomía oncológica. Acta Ortop Mex 2011;25(2):93-98.

13. Marrone PA, Rondón NM, Winterdaal DM, et al. Efecto de la terapia inmunosupresora sobre el trasplante renal. MEDICRIT 2005;2(3):29-33.

14. Ozaki T, Hillmann A, Bettin D, et al. High complication rates with pelvic allograft: Experience of 22 sarcoma resections. Acta Orthop Scand 1996;67(4):333-338.